Tag: point-of-care molecular diagnostics market trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Predicted Market Size Trajectory For The Point-Of-Care Molecular Diagnostics Market From 2025 To 2034?#_x000D_

The landscape of point-of-care molecular diagnostics has witnessed substantial expansion lately, projected to advance from a valuation of $3.55 billion in 2024 to $3.98 billion just one year later in 2025, reflecting a consistent annual growth rate (CAGR) of 12.0%. Key factors driving this upward trend during the past period include a rising necessity for swift disease identification, the proliferation of infectious disease incidents, the broadening scope of telemedicine applications and decentralized testing, supportive regulatory environments for diagnostics performed at the site of care, and the growing requirement for treatments tailored to individual precision medicine needs._x000D_

_x000D_

Anticipation suggests the market for point-of-care molecular diagnostics is poised for substantial expansion in the ensuing years, with projections indicating it will reach a valuation of $6.92 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.8%. This upsurge during the projection timeframe owes its momentum to several key factors, such as the continuous reduction in size of diagnostic instruments, the broadening application of POC testing across oncology and hereditary conditions, the tailored development of molecular diagnostics for a variety of uses, the incorporation of artificial intelligence and deep learning methods for interpreting data, and ongoing efforts in monitoring outbreaks of previously unknown infectious diseases. Furthermore, significant shifts shaping this market as foreseen include the adoption of lab-on-a-chip and microfluidic innovations, the convergence of digital health with diagnostics accessible via smartphones, heightened focus on point-of-care solutions for managing COVID-19 and preparing for future pandemics, the rise of diagnostic tools that use AI to forecast outcomes, and the advent of testing platforms based on CRISPR technology._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp_x000D_

_x000D_

#What Are The Key Drivers Of Growth In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The escalating prevalence of contagious and respiratory ailments is projected to be a major impetus for expansion within the market for point-of-care molecular diagnostics. Illnesses affecting the respiratory tract, brought on by bacterial or viral agents, involve microorganisms impacting breathing functions, and transmission typically occurs through aerosolized droplets from coughing or sneezing, or via direct physical contact; the spectrum of therapeutic interventions for these respiratory conditions ranges from inhaled devices and prescribed oral drugs to intravenous therapies and, crucially, point-of-care molecular diagnostic tools for patient management. Illustratively, official data released by the Office for National Statistics, the recognized national statistical body in the United Kingdom, indicated that for the week concluding December 9, 2022, infection rates in England specifically saw an upward trend among individuals aged 35 to 69, along with a rise observed in the 12 to 24 age cohort; consequently, the heightened incidence of fatal and non-fatal respiratory and infectious diseases acts as a powerful factor fueling the growth trajectory of the point-of-care molecular diagnostics industry._x000D_

_x000D_

#What Are The Leading Segments Analyzed In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The point-of-care molecular diagnosticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services_x000D_

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing_x000D_

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology_x000D_

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_

_x000D_

Subsegments:_x000D_

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers_x000D_

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services_x000D_

_x000D_

#Which Competitive Trends Are Defining The Point-Of-Care Molecular Diagnostics Market Structure?#_x000D_

A significant driver currently influencing the landscape of point-of-care molecular diagnostics is the escalating momentum behind technological advancements. Leading entities within this market are directing their efforts toward delivering solutions that incorporate sophisticated technology, thereby solidifying their competitive standing. These corporations are actively integrating cutting-edge molecular diagnostics at the point of care, including methodologies like ELISA, PCR, mass spectrometry, in situ hybridizations, SK imaging, and DNA microarrays, deploying them in POC instruments engineered to reduce turnaround times and decrease operational expenditures. As a tangible example, in May of 2023, the diagnostic firm Sensible Diagnostics, based in the United States, introduced a PCR system capable of delivering results in just ten minutes, leveraging the diagnostic proficiency accumulated by Curative throughout the pandemic; this PCR platform boasts a ten-minute result window, substantiated by the fact that the company has successfully processed upwards of two million COVID-19 molecular tests at the point of care._x000D_

_x000D_

#Who Are The Key Multinational Companies Dominating The Point-Of-Care Molecular Diagnostics Market?#_x000D_

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc. _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report_x000D_

_x000D_

#What Are The Regional Market Dynamics Impacting The Point-Of-Care Molecular Diagnostics Industry?#_x000D_

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Point-Of-Care Molecular Diagnostics Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2025, By The Business Research Company#_x000D_

_x000D_

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

Molecular Diagnostics Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report_x000D_

_x000D_

Molecular Diagnostics Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Predicted Market Size Trajectory For The Point-Of-Care Molecular Diagnostics Market From 2025 To 2034?#_x000D_

The landscape of point-of-care molecular diagnostics has witnessed substantial expansion lately, projected to advance from a valuation of $3.55 billion in 2024 to $3.98 billion just one year later in 2025, reflecting a consistent annual growth rate (CAGR) of 12.0%. Key factors driving this upward trend during the past period include a rising necessity for swift disease identification, the proliferation of infectious disease incidents, the broadening scope of telemedicine applications and decentralized testing, supportive regulatory environments for diagnostics performed at the site of care, and the growing requirement for treatments tailored to individual precision medicine needs._x000D_

_x000D_

Anticipation suggests the market for point-of-care molecular diagnostics is poised for substantial expansion in the ensuing years, with projections indicating it will reach a valuation of $6.92 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.8%. This upsurge during the projection timeframe owes its momentum to several key factors, such as the continuous reduction in size of diagnostic instruments, the broadening application of POC testing across oncology and hereditary conditions, the tailored development of molecular diagnostics for a variety of uses, the incorporation of artificial intelligence and deep learning methods for interpreting data, and ongoing efforts in monitoring outbreaks of previously unknown infectious diseases. Furthermore, significant shifts shaping this market as foreseen include the adoption of lab-on-a-chip and microfluidic innovations, the convergence of digital health with diagnostics accessible via smartphones, heightened focus on point-of-care solutions for managing COVID-19 and preparing for future pandemics, the rise of diagnostic tools that use AI to forecast outcomes, and the advent of testing platforms based on CRISPR technology._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp_x000D_

_x000D_

#What Are The Key Drivers Of Growth In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The escalating prevalence of contagious and respiratory ailments is projected to be a major impetus for expansion within the market for point-of-care molecular diagnostics. Illnesses affecting the respiratory tract, brought on by bacterial or viral agents, involve microorganisms impacting breathing functions, and transmission typically occurs through aerosolized droplets from coughing or sneezing, or via direct physical contact; the spectrum of therapeutic interventions for these respiratory conditions ranges from inhaled devices and prescribed oral drugs to intravenous therapies and, crucially, point-of-care molecular diagnostic tools for patient management. Illustratively, official data released by the Office for National Statistics, the recognized national statistical body in the United Kingdom, indicated that for the week concluding December 9, 2022, infection rates in England specifically saw an upward trend among individuals aged 35 to 69, along with a rise observed in the 12 to 24 age cohort; consequently, the heightened incidence of fatal and non-fatal respiratory and infectious diseases acts as a powerful factor fueling the growth trajectory of the point-of-care molecular diagnostics industry._x000D_

_x000D_

#What Are The Leading Segments Analyzed In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The point-of-care molecular diagnosticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services_x000D_

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing_x000D_

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology_x000D_

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_

_x000D_

Subsegments:_x000D_

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers_x000D_

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services_x000D_

_x000D_

#Which Competitive Trends Are Defining The Point-Of-Care Molecular Diagnostics Market Structure?#_x000D_

A significant driver currently influencing the landscape of point-of-care molecular diagnostics is the escalating momentum behind technological advancements. Leading entities within this market are directing their efforts toward delivering solutions that incorporate sophisticated technology, thereby solidifying their competitive standing. These corporations are actively integrating cutting-edge molecular diagnostics at the point of care, including methodologies like ELISA, PCR, mass spectrometry, in situ hybridizations, SK imaging, and DNA microarrays, deploying them in POC instruments engineered to reduce turnaround times and decrease operational expenditures. As a tangible example, in May of 2023, the diagnostic firm Sensible Diagnostics, based in the United States, introduced a PCR system capable of delivering results in just ten minutes, leveraging the diagnostic proficiency accumulated by Curative throughout the pandemic; this PCR platform boasts a ten-minute result window, substantiated by the fact that the company has successfully processed upwards of two million COVID-19 molecular tests at the point of care._x000D_

_x000D_

#Who Are The Key Multinational Companies Dominating The Point-Of-Care Molecular Diagnostics Market?#_x000D_

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc. _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report_x000D_

_x000D_

#What Are The Regional Market Dynamics Impacting The Point-Of-Care Molecular Diagnostics Industry?#_x000D_

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Point-Of-Care Molecular Diagnostics Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2025, By The Business Research Company#_x000D_

_x000D_

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

Molecular Diagnostics Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report_x000D_

_x000D_

Molecular Diagnostics Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Point-Of-Care Molecular Diagnostics Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

The market size of point-of-care molecular diagnostics has witnessed significant expansion in the past few years. The value is projected to escalate from $3.55 billion in 2024 to $3.98 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.0%. This substantial growth during the historical phase is primarily owing to the surge in the necessity for quick disease diagnosis, an increase in infectious disease epidemics, growth of telemedicine and remote testing, regulatory backing for point-of-care diagnostics, and the requirement for personalized and precision medicine._x000D_

_x000D_

The market for point-of-care molecular diagnostics is forecast to see robust growth in the forthcoming years. It’s anticipated to reach $6.92 billion by 2029, expanding at a compound annual growth rate (CAGR) of 14.8%. Factors contributing to the growth during the forecast period include the miniaturization of diagnostic devices, larger-scale point-of-care screening for cancers and genetic disorders, tailored molecular diagnoses for different uses, and the incorporation of artificial intelligence and machine learning for data interpretation, as well as the monitoring of emerging infectious diseases. Key trends expected during the forecast period are lab-on-a-chip and microfluidic technologies, digital health advances, smartphone-based diagnostics, readiness for point-of-care covid-19 and other pandemics, predictive diagnostics powered by AI, and testing based on crispr molecular technology._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Point-Of-Care Molecular Diagnostics Industry?#_x000D_

The escalating prevalence of infectious and respiratory illnesses is anticipated to substantially fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, triggered by viruses or bacteria, result from microorganisms affecting the respiratory system. These pathogens can be disseminated through actions like coughing, sneezing, or physical contact. The spectrum of treatments for these conditions is broad, encompassing inhalers, oral drugs, intravenous therapies, and point-of-care molecular diagnoses to help patients recover. For instance, data from the Office for National Statistics, a reputed national statistics institute from the UK, reveals a spike in the infection rate in people between 35 to 69 years of age and school-year students aged 12 to 24 years, as of the week ended December 9, 2022. Therefore, the swiftly rising rates of infectious and respiratory ailments and related fatalities will catalyze the growth of the point-of-care-molecular diagnostics market._x000D_

_x000D_

#How Is the Point-Of-Care Molecular Diagnostics Market Segmented?#_x000D_

The point-of-care molecular diagnosticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services_x000D_

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing_x000D_

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology_x000D_

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_

_x000D_

Subsegments:_x000D_

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers_x000D_

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Point-Of-Care Molecular Diagnostics Market Growth?#_x000D_

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Point-Of-Care Molecular Diagnostics Industry?#_x000D_

The rise of technology-based innovation is a fundamental trend gaining traction in the point-of-care molecular diagnostics industry. Major players in this market are concentrating on offering high-tech solutions to bolster their market stature. These businesses are adopting cutting-edge technologies and associated services in point-of-care molecular diagnostics, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), along with situ hybridizations, spectral karyotyping imaging, and DNA microarrays. These technologies are being utilized on POC devices to expedite analysis times and reduce expenditure. For instance, Sensible Diagnostics, a diagnostic firm based in the United States, unveiled a point-of-care PCR system with a 10-minute turnaround time in May 2023. Sensible Diagnostics is leveraging the expertise it gained from Curative’s diagnostics operations during the pandemic, having conducted over two million point-of-care COVID-19 molecular tests, demonstrating the efficacy of its PCR platform, which yields results in just 10 minutes._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report_x000D_

_x000D_

#How Is the Point-Of-Care Molecular Diagnostics Market Defined and What Are Its Core Parameters?#_x000D_

Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases. Point-of-care (POC) molecular diagnostic is used to detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS)._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Point-Of-Care Molecular Diagnostics Market from 2024 to 2025?

The market size of point-of-care molecular diagnostics has seen a significant rise recently. It is projected to escalate from $3.55 billion in 2024 to $4.01 billion in 2025, showcasing a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the past growth include a surge in requirements for swift disease diagnosis, a rise in incidents of infectious diseases, the enlargement of telemedicine and distant testing, regulatory backing for point-of-care diagnostics, and the demand for customized and precision medicine.

What Is the Projected Market Size of the Point-Of-Care Molecular Diagnostics Market?

The market for point-of-care molecular diagnostics is projected to witness substantial growth in the upcoming years, swelling to a valuation of $7.02 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 15.0%. Factors contributing to this anticipated rise during the forecast period includes the miniaturization of diagnostic devices, growing scope of point-of-care testing for cancer and genetic diseases, personalized molecular diagnostics for varying applications, the incorporation of artificial intelligence and machine learning for data examination, and growing awareness of emerging infectious diseases. Noteworthy trends for the predicted period consist of lab-on-a-chip and microfluidic technologies, smartphone-focused diagnostics and digital health, preparedness for point-of-care Covid-19 and other pandemics, predictive diagnostics powered by AI, and CRISPR-based molecular testing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

Who are the Major Competitors in the Point-Of-Care Molecular Diagnostics Market Outlook?

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.

What Is Fueling Growth in the Point-Of-Care Molecular Diagnostics Market?

The quick surge in infectious and respiratory diseases is anticipated to significantly influence the growth of the point-of-care molecular diagnostics market. Respiratory infections including bacteria or viruses are triggered by microorganisms impacting the respiratory system. These pathogens can be propagated through coughs, sneezes, or direct contact. The complexity of the respiratory medications encompasses a range of inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostic tools to treat the patient. For example, the Office for National Statistics, a recognized statistics institute in the UK, reported that in England at the end of the week concluding on December 9, 2022, the rate of infection spiked for individuals aged between 35 and 69, and also elevated for those in school years 12 to 24. Consequently, the swift rise of infectious and respiratory diseases will propel the point-of-care molecular diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp

Which Point-Of-Care Molecular Diagnostics Market Segments Are Growing the Fastest?

The point-of-care molecular diagnostics market covered in this report is segmented –

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services

Which Industry Trends Are Shaping the Future of the Point-Of-Care Molecular Diagnostics Market?

The rise of technological innovation is a prominent trend in the point-of-care molecular diagnostics market. Leading companies in this market are strategically utilizing advanced technology to reinforce their market presence. They are deploying cutting-edge point-of-care molecular diagnostics technological solutions and related services such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and more. These technologies are incorporated into POC devices to speed up analysis times and reduce costs. An illustration of this trend occurred in May 2023, when US diagnostics company Sensible Diagnostics introduced a 10-minute point-of-care PCR system. The firm drew from its experience gained through the pandemic and has administered over two million molecular point-of-care COVID-19 tests. It’s PCR platform boasts a rapid 10-minute time-to-result.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Which Countries Are Leading the Point-Of-Care Molecular Diagnostics Market?

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046

This Report Delivers Insight On:

1. How big is the point-of-care molecular diagnostics market, and how is it changing globally?

2. Who are the major companies in the point-of-care molecular diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the point-of-care molecular diagnostics market right now?

4. Which products or customer segments are growing the most in the point-of-care molecular diagnostics market?

5. What factors are helping or slowing down the growth of the point-of-care molecular diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Point-Of-Care Molecular Diagnostics Market?

The increasing frequency of infectious and respiratory diseases is expected to contribute to the growth of the point-of-care molecular diagnostics market. Respiratory infections, often spread through airborne microorganisms, require various treatments including point-of-care diagnostics. According to the Office for National Statistics, infection rates in the UK increased in 2022, particularly among individuals aged 35-69 and school-age children. This rise in infections will drive the demand for molecular diagnostic solutions at the point of care.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

#What Are the Key Projections for the CAGR of the Point-Of-Care Molecular Diagnostics Market From 2025 to 2034?

The point-of-care molecular diagnostics market has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $4.01 billion in 2025, with a compound annual growth rate (CAGR) of 12.9%. This growth is driven by the increasing demand for rapid disease diagnosis, rising infectious disease outbreaks, the expansion of telemedicine, and the need for personalized and precision medicine.

The point-of-care molecular diagnostics market is expected to reach $7.02 billion by 2029 at a CAGR of 15.0%. Growth drivers include the miniaturization of diagnostic devices, the expansion of POC testing for cancer and genetic diseases, and the integration of AI for data analysis. Trends include lab-on-a-chip technologies, smartphone-based diagnostics, AI-driven predictive diagnostics, and CRISPR-based molecular testing.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046

What Are the Key Market Innovations in thePoint-Of-Care Molecular Diagnostics Market Over the Coming Years?

Innovation in Android point-of-sale (PoS) terminals is a key trend in the point-of-sale terminals market, enhancing transaction efficiency and user experience. Android PoS terminals are electronic devices powered by the Android operating system to process sales transactions. In August 2023, BharatPe, an India-based fintech company, launched BharatPeSwipe Android, an Android PoS terminal that supports various payment methods such as debit/credit cards, UPI, mobile wallets, and QR codes. The terminal runs on Android 10 and features a long-lasting, fast-charging battery, allowing merchants to accept payments through dynamic QR codes and print physical receipts.

Who Are the Top Companies Driving Innovation and Growth in thePoint-Of-Care Molecular Diagnostics Market?

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Which Key Market Segments Comprise the Point-Of-Care Molecular Diagnostics Market and Drive Its Revenue Growth?

The point-of-care molecular diagnostics market covered in this report is segmented –

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp

Which Regions Are Emerging as Leaders in the Point-Of-Care Molecular Diagnostics Market?

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Point-Of-Care Molecular Diagnostics Maret 2025, By The Business Research Company:

Point of Care Ultrasound Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-ultrasound-global-market-report

Veterinary Point Of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-point-of-care-diagnostics-global-market-report

Point of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the point-of-care molecular diagnostics market grown over the years?

The market size for point-of-care molecular diagnostics has seen a significant expansion in the past few years. Projections indicate that the market will increase from $3.55 billion in 2024 to $4.01 billion in 2025, representing a compound annual growth rate (CAGR) of 12.9%. Several factors contributed to this growth during the historical phase, including a surge in demand for quick disease diagnosis, a rise in incidences of infectious diseases, the development of telemedicine and remote testing, regulatory encouragement for point-of-care diagnostics, and a growing requirement for personalized and precise medicine.

What Is the forecasted market size and growth rate for the point-of-care molecular diagnostics market?

The market size for point-of-care molecular diagnostics is anticipated to experience swift expansion in the upcoming years, reaching $7.02 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%. Various factors contributing to the growth during this forecast period include the reduction in size of diagnostic devices, extended point-of-care testing for cancer and genetic disorders, personalised molecular diagnostics for a variety of applications, and the implementation of artificial intelligence and machine learning for data interpretation. Emerging infectious disease monitoring is also a significant factor. Noteworthy advancements expected in the forecast period encompass lab-on-a-chip and microfluidic technologies, digital health coupled with smartphone-based diagnostics, readiness for point-of-care COVID-19 and other potential pandemics, predictive diagnostics powered by AI, and CRISPR-based molecular examinations.

Get your point-of-care molecular diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

What are the major factors driving growth in the point-of-care molecular diagnostics market?

The swift escalation in the prevalence of infectious and respiratory illnesses is projected to notably stimulate the progress of the point-of-care molecular diagnostics market. Respiratory infections, instigated by microorganisms such as viruses or bacteria that impact the respiratory system, can be transmitted by coughing, sneezing, or direct contact. The range of treatments for these severe respiratory ailments includes various inhalers, oral medications, intravenous therapies, and point-of-care molecular diagnostics to treat the patient. As reported by the Office for National Statistics, a reputable national statistics organization based in the UK, in England, as of the conclusion of the week ending December 9, 2022, the infection rate saw a rise in individuals aged 35 to 69 years and likewise surged for those in school years 12 to 24 years. Consequently, the swift rise in the incidence of infectious and respiratory diseases and related deaths will fuel the growth of the point-of-care molecular diagnostics market.

What key areas define the segmentation of the global point-of-care molecular diagnostics Market?

The point-of-care molecular diagnostics market covered in this report is segmented –

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

What are the top market players propelling the growth of the point-of-care molecular diagnostics industry?

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.

What are the key trends shaping the future of the point-of-care molecular diagnostics market?

Technological advancement is a burgeoning trend in the point-of-care molecular diagnostics market. The primary players in the point-of-care molecular diagnostic market are intent on offering cutting-edge solutions to consolidate their market footprint. They are rolling out novel point-of-care molecular diagnostic technologies and associated services such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, among others, to POC devices, with an aim to expedite analysis times and reduce costs. For example, in May 2023, Sensible Diagnostics, a diagnostics company based in the US, introduced a 10-minute point-of-care PCR system. Sensible Diagnostics capitalizes on the expertise acquired by Curative through its diagnostics operation in the pandemic era. The company divulged that it has carried out more than two million molecular point-of-care COVID-19 tests, and its PCR platform delivers results in just 10 minutes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046

What regions are dominating the point-of-care molecular diagnostics market growth?

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Point of Care Ultrasound Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-ultrasound-global-market-report

Veterinary Point Of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-point-of-care-diagnostics-global-market-report

Point of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Point-Of-Care Molecular Diagnostics Market Over the Forecast Period of 2025 to 2034?

In recent times, there has been a swift expansion in the market size of point-of-care molecular diagnostics. The projections show an increase from $3.55 billion in 2024 to $4.01 billion in 2025, implying a compound annual growth rate (CAGR) of 12.9%. This upsurge during the past era occurs because of the growing requirement for immediate disease identification, the escalation of infectious disease occurrences, the widening of telemedicine and distant testing, regulatory backing for point-of-care diagnostics, and the necessity for individualized and precision medicine.

The market size of point-of-care molecular diagnostics is projected to undergo swift expansion in the coming years, reaching a valuation of $7.02 billion in 2029, with a compound annual growth rate (CAGR) of 15.0%. This growth during the forecasted period can be linked to factors such as the shrinkage of diagnostic devices, augmentation of point-of-care testing for cancer and genetic ailments, specialty molecular diagnostics for a plethora of applications, incorporation of artificial intelligence and machine learning for data interpretation, and the surveillance of emerging infectious diseases. Key trends expected during the forecast period comprise lab-on-a-chip and microfluidic technologies, digital health and smartphone-centric diagnostics, readiness for point-of-care COVID-19 and other pandemics, predictive diagnostics driven by AI, and molecular testing based on CRISPR.

What Key Drivers Are Accelerating the Growth of the point-of-care molecular diagnostics Market During the Forecast Period?

The escalating prevalence of infectious and respiratory diseases is anticipated to majorly fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, triggered by microorganisms such as viruses or bacteria, impact the respiratory system. These pathogens can be disseminated via coughing, sneezing, or direct contact. The assortment of treatments for severe respiratory diseases comprises various inhalers, oral medications, intravenous therapies, and point-of-care molecular diagnostics to treat the patient. For example, data from the Office for National Statistics, a respected national statistics organization in the UK, revealed that in England, the infection rate rose for individuals aged 35 to 69 years and also escalated for those in school years 12 to 24 years, by the end of the week concluding December 9, 2022. As a result, the swift surge in infectious and respiratory diseases and associated fatalities will stimulate the point-of-care molecular diagnostics market.

Request Your Free Point-Of-Care Molecular Diagnostics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

Who Are the Top Companies Driving Innovation and Growth in the Point-Of-Care Molecular Diagnostics Market?

Major companies operating in the point-of-care molecular diagnostics market include:

• Abbott Laboratories_x000D_

• F Hoffmann-La Roche Ltd._x000D_

• BioMérieux SA_x000D_

• Danaher Corporation_x000D_

• Quidel Corporation_x000D_

What Key Trends Are Currently Impacting the Point-Of-Care Molecular Diagnostics Market’s Development?

Technological advancement is becoming a significant trend in the point-of-care molecular diagnostics market. The leading companies in this market are focusing on delivering high-tech solutions to solidify their standing in the market. They are utilizing advanced point-of-care molecular diagnostics technology solutions and related services such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and others. These features aim to speed up analysis times and reduce costs when implemented on POC devices. As an example, in May 2023, US firm Sensible Diagnostics introduced a point-of-care PCR system that delivers results in 10 minutes. The company is leveraging the hands-on experience Curative accumulated during the pandemic in the diagnostics industry. The company reported having processed more than two million molecular point-of-care COVID-19 tests, and its PCR platform can produce results in as little as 10 minutes.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Which Key Segments Stand Out in Understanding the Composition of the Point-Of-Care Molecular Diagnostics Market?

The point-of-care molecular diagnostics market covered in this report is segmented –

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services

Which Geographical Regions Are Pioneering Growth in the Point-Of-Care Molecular Diagnostics Market?

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Aspects of the Point-Of-Care Molecular Diagnostics Market Landscape?

Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases. Point-of-care (POC) molecular diagnostic is used to detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS).

Browse Through More Similar Reports By The Business Research Company:

Point of Care Ultrasound Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-ultrasound-global-market-report

Veterinary Point Of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-point-of-care-diagnostics-global-market-report

Point of Care Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: